4
MARKET OVERVIEW
Presents a concise view of industry direction, strategic priorities, and key indicators influencing market momentum.
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Explains the evolving landscape through demand-side drivers, supply-side constraints, and opportunity hotspots.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.2
MACROECONOMIC OUTLOOK
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN US DENTAL CONSUMABLES INDUSTRY
5.3
SUPPLY CHAIN ANALYSIS
5.6.1
AVERAGE SELLING PRICE TREND, BY PRODUCT, 2022–2025
5.6.2
AVERAGE SELLING PRICE TREND OF DIFFERENT PRODUCTS, BY KEY PLAYER, 2022–2025
5.7.1
IMPORT SCENARIO (HS CODE 9018)
5.7.2
EXPORT SCENARIO (HS CODE 9018)
5.8
KEY CONFERENCES AND EVENTS, 2025–2026
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.10
INVESTMENT AND FUNDING SCENARIO
5.12
IMPACT OF 2025 US TARIFF – US PERIODONTAL DISEASE TREATMENT MARKET
5.12.3
PRICE IMPACT ANALYSIS
5.12.4
IMPACT ON END USERS
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, AND INNOVATIONS
6.1
KEY EMERGING TECHNOLOGIES
6.2
COMPLEMENTARY TECHNOLOGIES
6.3
TECHNOLOGY/PRODUCT ROADMAP
6.5
IMPACT OF AI/GEN AI ON US PERIODONTAL DISEASE TREATMENT MARKET
6.5.1
TOP USE CASES AND MARKET POTENTIAL
6.5.2
BEST PRACTICES FOLLOWED BY PLAYERS IN US PERIODONTAL DISEASE TREATMENT MARKET
6.5.3
CASE STUDIES OF AI IMPLEMENTATION IN THE US PERIODONTAL DISEASE TREATMENT MARKET
6.54INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.5.5
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PERIODONTAL DISEASE TREATMENT MARKET
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
CERTIFICATIONS, LABELING, ECO-STANDARDS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.2
DECISION MAKING PROCESS
8.3
KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
8.3.1
KEY STAKEHOLDERS IN BUYING PROCESS
8.4
ADOTPION BARRIERS AND INTERNAL CHALLENGES
8.5
UNMET NEEDS OF VARIOUS END USERS
9
US PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE (MARKET SIZE & FORECAST TO 2031 – VALUE USD MILLION) & VOLUME (UNITS) 2023 TO
9.2.2
RECURRENT GINGIVITIS
9.3
CHRONIC PERIODONTITIS
9.4
AGGRESSIVE PERIODONTITIS
10
US PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT (MARKET SIZE & FORECAST TO 2031 – VALUE (USD MILLION) & VOLUME (UNITS) 2023 TO
11
US PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT (MARKET SIZE & FORECAST TO 2031 – VALUE (USD MILLION) & VOLUME (UNITS) 2023 TO
11.2
NON-SURGICAL TREATMENT
11.2.3
MEDICATION THERAPY
11.2.3.2
SYSTEMIC THERAPY
11.3
FLAP SURGERY/POCKET REDUCTION THERAPY
11.6
GUIDED TISSUE REGENERATION
12
US PERIODONTAL DISEASE TREATMENT MARKET, BY END USER (MARKET SIZE & FORECAST TO 2031– VALUE USD MILLION) 2023 TO
12.3
PRIVATE AND DSO CLINICS
12.4
ACADEMIC AND RESEARCH INSTITUTES
13.2
KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN
13.3
REVENUE SHARE ANALYSIS OF KEY PLAYERS, 2020 -
13.4
MARKET SHARE ANALYSIS,
13.5
BRAND/PRODUCT/TECHNOLOGY COMPARISON
13.6
COMPANY EVALUATION MATRIX: KEY PLAYERS,
13.6.5
COMPANY FOOTPRINT: KEY PLAYERS,
11.6.5.1
COMPANY FOOTPRINT
11.6.5.2
DISEASE FOOTPRINT
11.6.5.3
PRODUCT FOOTPRINT
11.6.5.4
TREATMENT FOOTPRINT
11.6.5.3
END USER FOOTPRINT
13.7
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
13.7.1
PROGRESSIVE COMPANIES
13.7.2
RESPONSIVE COMPANIES
13.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
13.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
13.7.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
13.8
COMPETITIVE SCENARIO
13.8.4
OTHER DEVELOPMENTS
13.9
COMPANY VALUATION AND FINANCIAL METRICS
14.1.1.1
BUSINESS OVERVIEW
14.1.1.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
14.1.1.3
RECENT DEVELOPMENTS
14.1.1.4.2
STRATEGIC CHOICES
14.1.1.4.3
WEAKNESS & COMPETITIVE THREATS
14.1.3
INSTITUT STRAUMANN AG
14.1.5
BIOLASE MG LLC (SUBSIDIARY OF MEGA’GEN IMPLANT CO., LTD)
14.1.6
GEISTLICH PHARMA AG.
14.1.11
YOSHIDA DENTAL MFG. CO., LTD.
14.1.12
KEYSTONE DENTAL GROUP
14.1.13
ULTRADENT PRODUCTS INC.
14.2.14
BEGO GMBH & CO. KG
15.1.1.1
KEY DATA FROM SECONDARY SOURCES
15.1.1.2
LIST OF SECONDARY SOURCES
15.1.2.1
KEY DATA FROM PRIMARY SOURCES
15.1.2.2
KEY PRIMARY PARTICIPANTS
15.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
15.1.2.4
KEY INDUSTRY INSIGHTS
15.2
MARKET SIZE ESTIMATION
15.2.1
BOTTOM-UP APPROACH
15.2.3
BASE NUMBER CALCULATION
15.3
MARKET FORECAST APPROACH
15.6
RESEARCH ASSUMPTIONS
15.7
RESEARCH LIMITATIONS
16.1
INSIGHTS FROM INDUSTRY EXPERTS
16.3
KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.4
AVAILABLE CUSTOMIZATION
Growth opportunities and latent adjacency in US Periodontal Disease Treatment Market